Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk

NCT05028829 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Liver Fibroses
Cirrhosis

Interventions

DRUG: Atorvastatin 20mg
DRUG: Placebo

Sponsor

Raymond Chung

Collaborators

[object Object]